1Ketter TA,Calabrese JR.Stabilization of mood from below versus above the baseline in bipolar disorder:a new nomenclature.J Clin Psychiatry,2002,63(2):146～151.
2David MD.Drug interactions of lithium and other antimanic /mood-stabilizing medications.J Clin Psychiatry,2003,64(Suppl 5):39～43.
3Tidwell A,Swims M.Review of the newer antiepileptic drugs.Am J Manag Care,2003,9(3):253～276.
4Verdoux H,Gonzales B,Takei N,et al.A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive out-patients.J Affect Disord,1996,38(2-3):81～87.
7Suppes T,Webb A,Paul B,et al.Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and history of mania.Am J Psychiatry,1999,156(8):1164～1169.
8Vieta E,Goikolea JM,Corbella B,et al.Risperidone safety and efficacy in the treatment of bipolar and schizaffective disorders:results from a 6-month,multicenter,open study,J Clin Psychiatry,2001,62(10):818～825.
10Tohen M,Sanger TM,McElroy SL,et al.Olanzapine versus placebo in the treatment of acute mania.Olanzapine HGEH Study Group.Am J Psychiatry,1999,156(5):702～709.
10Segal J,Beck M,Rrook S.Rispendone compared with both lithium and haloperidol in mania:a double-blind randomized controlled trail[J].Clin Neuropharmacol,1998,21(3):176.
